Lisicki Robert 4
4 · Cadrenal Therapeutics, Inc. · Filed Jul 24, 2023
Insider Transaction Report
Form 4
Lisicki Robert
Director
Transactions
- Award
Stock options
2023-07-23+75,000→ 75,000 totalExercise: $1.20From: 2024-08-01Exp: 2033-07-23→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]Consists of options to purchase 75,000 shares of common stock, which shall vest over a period of three years, with 1/3 vesting on August 1, 2024 and thereafter 1/36 on a monthly basis.